Your browser doesn't support javascript.
loading
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.
Ampuero, Javier; Aller, Rocío; Gallego-Durán, Rocío; Crespo, Javier; Calleja, Jose Luis; García-Monzón, Carmelo; Gómez-Camarero, Judith; Caballería, Joan; Lo Iacono, Oreste; Ibañez, Luis; García-Samaniego, Javier; Albillos, Agustín; Francés, Rubén; Fernández-Rodríguez, Conrado; Maya-Miles, Douglas; Diago, Moisés; Poca, Maria; Andrade, Raúl J; Latorre, Raquel; Jorquera, Francisco; Morillas, Rosa María; Escudero, Desamparados; Hernández-Guerra, Manuel; Pareja-Megia, María Jesús; Banales, Jesús M; Aspichueta, Patricia; Benlloch, Salvador; Rosales, José Miguel; Turnes, Juan; Romero-Gómez, Manuel.
Afiliação
  • Ampuero J; Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Seville, Spain. jampuero-ibis@us.es.
  • Aller R; SeLiver Group, Instituto de Biomedicina de Sevilla, Seville, Spain. jampuero-ibis@us.es.
  • Gallego-Durán R; Digestive Disease Department and CIBERehd, Virgen del Rocio University Hospital, Avenida Manuel Siurot S/N, 41013, Seville, Spain. jampuero-ibis@us.es.
  • Crespo J; Centro de Investigación de Endocrinología y Nutrición, Hospital Clínico Universitario de Valladolid, Universidad de Valladolid, Valladolid, Spain.
  • Calleja JL; SeLiver Group, Instituto de Biomedicina de Sevilla, Seville, Spain.
  • García-Monzón C; Digestive Disease Department and CIBERehd, Virgen del Rocio University Hospital, Avenida Manuel Siurot S/N, 41013, Seville, Spain.
  • Gómez-Camarero J; Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Caballería J; Hospital Universitario Puerta de Hierro, Madrid, Spain.
  • Lo Iacono O; Liver Research Unit, Hospital Universitario Santa Cristina Instituto de Investigación Sanitaria Princesa Madrid, Madrid, Spain.
  • Ibañez L; Hospital Universitario de Burgos, Burgos, Spain.
  • García-Samaniego J; Digestive Disease Department and CIBERehd, Virgen del Rocio University Hospital, Avenida Manuel Siurot S/N, 41013, Seville, Spain.
  • Albillos A; Liver Unit. Hospital Clínic. Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBPAS), Barcelona, Spain.
  • Francés R; Hospital Universitario Tajo, Aranjuez, Spain.
  • Fernández-Rodríguez C; Digestive Disease Department and CIBERehd, Virgen del Rocio University Hospital, Avenida Manuel Siurot S/N, 41013, Seville, Spain.
  • Maya-Miles D; Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Diago M; Digestive Disease Department and CIBERehd, Virgen del Rocio University Hospital, Avenida Manuel Siurot S/N, 41013, Seville, Spain.
  • Poca M; Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
  • Andrade RJ; Digestive Disease Department and CIBERehd, Virgen del Rocio University Hospital, Avenida Manuel Siurot S/N, 41013, Seville, Spain.
  • Latorre R; Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Jorquera F; Digestive Disease Department and CIBERehd, Virgen del Rocio University Hospital, Avenida Manuel Siurot S/N, 41013, Seville, Spain.
  • Morillas RM; Hospital General Universitario de Alicante, Universidad Miguel Hernández, Elche, Spain.
  • Escudero D; Hospital Universitario Fundación de Alcorcón, Universidad Rey Juan Carlos, Móstoles, Spain.
  • Hernández-Guerra M; SeLiver Group, Instituto de Biomedicina de Sevilla, Seville, Spain.
  • Pareja-Megia MJ; Digestive Disease Department and CIBERehd, Virgen del Rocio University Hospital, Avenida Manuel Siurot S/N, 41013, Seville, Spain.
  • Banales JM; Hospital General Universitario de Valencia, Valencia, Spain.
  • Aspichueta P; Digestive Disease Department and CIBERehd, Virgen del Rocio University Hospital, Avenida Manuel Siurot S/N, 41013, Seville, Spain.
  • Benlloch S; Hospital de la Santa Creu i San Pau, Barcelona, Spain.
  • Rosales JM; Digestive Disease Department and CIBERehd, Virgen del Rocio University Hospital, Avenida Manuel Siurot S/N, 41013, Seville, Spain.
  • Turnes J; Unidad de Gestión Clínica de Enfermedades Digestivas, Instituto de Investigación Biomédica de Málaga-IBIMA-Plataforma BIONAND, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Malaga, Spain.
  • Romero-Gómez M; Hospital Universitari Son Llátzer, Mallorca, Spain.
J Gastroenterol ; 59(7): 586-597, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38619600
ABSTRACT

BACKGROUND:

MASLD can manifest as hepatocellular damage, which can result in mild elevation of aminotransferases. However, in some patients, MASLD presents with cholestatic pattern.

OBJECTIVE:

To assess the impact of the biochemical pattern on the natural course of MASLD, including liver damage in histology, the accuracy of non-invasive tests(NITs), and prognosis.

METHODS:

Multicenter study enrolling 2156 patients with biopsy-proven MASLD, who were classified based on their[ALT/ULN)]/[(ALP/ULN)] levels at the time of biopsy (a) hepatocellular pattern(H), > 5; (b) mixed pattern(M),2-5; (c) cholestatic pattern(C), < 2.

OUTCOMES:

(a) histological evaluation of the single components of NAS, MASH, and fibrosis; (b) NITs and transient elastography assessing advanced fibrosis; (c) prognosis determined by the appearance of decompensated cirrhosis and death.

RESULTS:

Out of the 2156 patients, 22.9% exhibited the H-pattern, whilst 31.7% exhibited the C-pattern. Severe steatosis, ballooning, lobular inflammation, and MASH (56.4% H vs. 41.9% M vs. 31.9% C) were more common in H-pattern (p = 0.0001),whilst C-pattern was linked to cirrhosis (5.8% H vs. 5.6% M vs. 10.9% C; p = 0.0001). FIB-4(0.74(95% CI 0.69-0.79) vs. 0.83 (95% CI 0.80-0.85); p = 0.005) and Hepamet Fibrosis Score(0.77 (95% CI 0.69-0.85) vs. 0.84 (95% CI 0.80-0.87); p = 0.044)exhibited lower AUROCs in the H-pattern. The C-pattern[HR 2.37 (95% CI 1.12-5.02); p = 0.024], along with age, diabetes, and cirrhosis were independently associated with mortality. Most patients maintained their initial biochemical pattern during the second evaluation.

CONCLUSIONS:

The H-pattern exhibited greater necro-inflammation in the histology than the C-pattern, whereas the latter showed more cirrhosis. The accuracy of NITs in detecting fibrosis was decreased in H-pattern. The occurrence of decompensated events and mortality was predominant in C-pattern. Therefore, identifying MASLD phenotypes based on the biochemical presentation could be relevant for clinical practice.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenótipo Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenótipo Idioma: En Ano de publicação: 2024 Tipo de documento: Article